We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

143 hedge funds and large institutions have $669M invested in Intellia Therapeutics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 31

44% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 18

14% more capital invested

Capital invested by funds: $589M → $669M (+$80.7M)

5% more funds holding

Funds holding: 136 → 143 (+7)

3.1% more ownership

Funds ownership: 90.23% → 93.33% (+3.1%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

32% less call options, than puts

Call options by funds: $2.35M | Put options by funds: $3.46M

Holders
143
Holders Change
+7
Holders Change %
+5.15%
% of All Funds
2.82%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
45
Reduced
31
Closed
18
Calls
$2.35M
Puts
$3.46M
Net Calls
-$1.11M
Net Calls Change
-$2.66M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.6M
2
Citadel Advisors
Citadel Advisors
Florida
+$7.47M
3
N
Nuveen
North Carolina
+$6.28M
4
AIM
ARK Investment Management
Florida
+$3.77M
5
AG
Artal Group
Luxembourg
+$2.78M

Top Sellers

Rank Fund Capital Flow
1
OTPPB
Ontario Teachers' Pension Plan Board
Ontario, Canada
-$10.7M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$3.54M
3
State Street
State Street
Massachusetts
-$1.85M
4
CS
Candriam SCA
Luxembourg
-$1.6M
5
UBS Group
UBS Group
Switzerland
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Trading
101
Walleye Trading
New York
$90K +$85.4K +6,138 New
LTFS
102
Ladenburg Thalmann Financial Services
Florida
$80K +$4.17K +300 +6%
BNP Paribas Financial Markets
103
BNP Paribas Financial Markets
France
$78.4K -$12.4K -892 -14%
Bank of Montreal
104
Bank of Montreal
Ontario, Canada
$77K +$18.1K +1,300 +33%
ETC
105
Exchange Traded Concepts
Oklahoma
$56K +$52.7K +3,785 New
QT
106
Quantbot Technologies
New York
$55K -$23.4K -1,681 -31%
AG
107
Advisor Group
Arizona
$48K – – –
AIP
108
Ameritas Investment Partners
Nebraska
$45K – – –
Walleye Capital
109
Walleye Capital
New York
$38K -$12.9K -924 -26%
WAP
110
Wealthcare Advisory Partners
Pennsylvania
$37K +$35.5K +2,550 New
Canada Life
111
Canada Life
Manitoba, Canada
$35K +$33.2K +2,388 New
KFS
112
Kelly Financial Services
Massachusetts
$33.7K – – –
TIM
113
Tortoise Investment Management
New York
$29K – – –
BEI
114
Benjamin Edwards Inc
Missouri
$28K +$3.1K +223 +13%
Zurich Cantonal Bank
115
Zurich Cantonal Bank
Switzerland
$25K – – –
AWM
116
AllSquare Wealth Management
New York
$16K – – –
KBC Group
117
KBC Group
Belgium
$15K -$40.9K -2,940 -74%
SPIA
118
Steward Partners Investment Advisory
New York
$13K – – –
VFA
119
Valeo Financial Advisors
Indiana
$11K – – –
CFA
120
Carroll Financial Associates
North Carolina
$10K – – –
APWM
121
Atlas Private Wealth Management
New York
$10K +$9.41K +676 New
BFEC
122
Benjamin F. Edwards & Company
Missouri
$8K – – –
HIA
123
Harbor Investment Advisory
Maryland
$7K +$6.96K +500 New
WT
124
Whittier Trust
California
$6K – – –
APA
125
American Portfolios Advisors
New York
$5.27K – – –
3 4
5
6 7

NTLA Hedge Fund Activity: Q4 2019 in Review

143 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q4 2019, worth a combined $669M — up 14% from $589M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new NTLA positions and 18 closed out — a net gain of 8 holders — while 45 added to existing stakes and 31 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $10.6M. The largest seller was Ontario Teachers' Pension Plan Board, exiting entirely with an estimated $10.7M sold.

  • 143 institutional investors held Intellia Therapeutics (NTLA) as of Q4 2019, up from 136 in Q3 2019.
  • Funds reported $669M of Intellia Therapeutics stock for Q4 2019, up 14% quarter-over-quarter.
  • 26 funds opened new Intellia Therapeutics positions in Q4 2019 and 18 closed out, a net change of +8 holders.
  • The largest Intellia Therapeutics buyer in Q4 2019 was Fidelity Investments, an estimated $10.6M added.
  • The largest Intellia Therapeutics seller in Q4 2019 was Ontario Teachers' Pension Plan Board, an estimated $10.7M sold.

Based on aggregated 13F filings for Q4 2019.